Purpose: Recent studies have suggested relative radioresistance in glioblas
toma multiforme (GM) tumors in older patients, consistent with their shorte
r survival. Two common molecular genetic abnormalities in GM are age relate
d: epidermal growth factor receptor (EGFR) overexpression in older patients
and p53 mutations in younger patients. We tested whether these abnormaliti
es correlated with clinical heterogeneity in GM response to radiation treat
ment.
Methods and Materials: Radiographically assessed radiation response (5-leve
l scale) was correlated with EGFR immunoreactivity, p53-immunoreactivity, a
nd p53 exon 5-8 mutation status in 170 GM patients treated using 2 prospect
ive clinical protocols. Spearman rank correlation and proportional-odds ord
inal regression were used for univariate and multivariate analysis.
Results: Positive EGFR immunoreactivity predicted poor radiographically ass
essed radiation response (p = 0.46). Thirty-three percent of tumors with no
EGFR immunoreactivity had good radiation responses (> 50% reduction in tum
or size by CT or MRI), compared to 18% of tumors with intermediate EGFR sta
ining and 9% of tumors with strong staining. There was no significant relat
ionship between p53 immunoreactivity or mutation status and radiation respo
nse. Significant relationships were noted between EGFR score and older age
and between p53 score or mutation status and younger age.
Conclusion: The observed relative radioresistance of some GMs is associated
with overexpression of EGFR. (C) 2001 Elsevier Science Inc.